No. J9075 is a HCPCS Level II code, maintained by CMS, that identifies a drug with no specific code of its own. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code.

What NDC goes with J9075?

None is fixed. J9075 is used for drugs that have no specific HCPCS code, so the claim carries the NDC of the drug actually given and its quantity, and payers usually also ask for the drug name and dose.

What is the Medicare payment limit for J9075?

$0.692 per 5 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.

J9075 J-Code: Cyclophosphamide — Billing Units & NDCs

In short

J9075 is the HCPCS Level II code for injection, cyclophosphamide, not otherwise specified, 5 mg: drugs with no specific code of their own. It has no fixed drug or unit, so the claim carries the NDC of the drug given and its quantity.

Code

CMS HCPCS file

HCPCS codeJ9075

Billing unit5 mg

Descriptor: Injection, cyclophosphamide, not otherwise specified, 5 mg
Short descriptor: Inj, cyclophosphamide, nos
Code set: HCPCS Level II, maintained by CMS
Effective: Apr 1, 2024

The billing unit is read from the descriptor. Confirm it against the CMS file before billing.

Medicare Part B payment limit

CMS ASP file

Payment limit per unit$0.692

Per5 mg

Coinsurance20%

Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files

Units and claim line

Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.

HCPCS units

Modifier

NDC (11-digit)

NDC unit qualifier

NDC quantity

Enter the units to build the claim line.

NDCs billed under J9075

CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 41 NDCs to J9075 for Cyclophosphamide. Billing units per package are CMS’s figures for this code’s unit.

NDCs assigned to J9075 in the CMS ASP crosswalk
Drug	NDC (11-digit)	Labeler	Package	Billing units per package
Cyclophosphamide	00781-3233-94	Sandoz Inc.	1	100
Cyclophosphamide	00781-3244-94	Sandoz Inc.	1	200
Cyclophosphamide	00781-3255-94	Sandoz Inc.	1	400
Cyclophosphamide	10019-0938-01	Baxter Healthcare Corporation	1	100
Cyclophosphamide	10019-0939-01	Baxter Healthcare Corporation	1	200
Cyclophosphamide	10019-0942-01	Baxter Healthcare Corporation	1	400
Cyclophosphamide	10019-0943-01	Baxter Healthcare Corporation	1	100
Cyclophosphamide	10019-0944-01	Baxter Healthcare Corporation	1	200
Cyclophosphamide	10019-0945-01	Baxter Healthcare Corporation	1	400
Cyclophosphamide	10019-0955-01	Baxter Healthcare Corporation	1	100
Cyclophosphamide	10019-0956-01	Baxter Healthcare Corporation	1	200
Cyclophosphamide	10019-0957-01	Baxter Healthcare Corporation	1	400
Cyclophosphamide	16714-0857-01	Northstar RxLLC	1	200
Cyclophosphamide	16714-0858-01	Northstar RxLLC	1	400
Cyclophosphamide	16714-0859-01	Northstar RxLLC	1	100
Cyclophosphamide	25021-0247-50	Sagent Pharmaceuticals	1	100
Cyclophosphamide	25021-0248-51	Sagent Pharmaceuticals	1	200
Cyclophosphamide	25021-0249-51	Sagent Pharmaceuticals	1	400
Cyclophosphamide	39822-0250-01	XGen Pharmaceuticals DJB, Inc.	1	100
Cyclophosphamide	39822-0255-01	XGen Pharmaceuticals DJB, Inc.	1	200
Cyclophosphamide	39822-0260-01	XGen Pharmaceuticals DJB, Inc.	1	400
Cyclophosphamide	65219-0131-20	FreseniUS Kabi USA, LLC	1	200
Cyclophosphamide	65219-0133-20	FreseniUS Kabi USA, LLC	1	400
Cyclophosphamide	65219-0135-20	FreseniUS Kabi USA, LLC	1	100
Cyclophosphamide	68001-0442-26	BluePoint Laboratories	1	100
Cyclophosphamide	68001-0443-27	BluePoint Laboratories	1	200
Cyclophosphamide	68001-0444-32	BluePoint Laboratories	1	400
Cyclophosphamide	68001-0694-27	Bluepoint Laboratories	1	100
Cyclophosphamide	68001-0695-32	Bluepoint Laboratories	1	200
Cyclophosphamide	68001-0696-32	BluePoint Laboratories	1	400
Cyclophosphamide	70121-1238-01	Amneal Pharmaceuticals, LLC	1	100
Cyclophosphamide	70121-1239-01	Amneal Pharmaceuticals, LLC	1	200
Cyclophosphamide	70121-1240-01	Amneal Pharmaceuticals, LLC	1	400
Cyclophosphamide	72572-0083-01	Civica, Inc.	1	400
Cyclophosphamide	72572-0085-01	Civica, Inc.	1	200
Cyclophosphamide	72572-0087-01	Civica, Inc.	1	100
Cyclophosphamide	72603-0104-01	Northstar RxLLC	1	100
Cyclophosphamide	72603-0326-01	Northstar RxLLC	1	200
Cyclophosphamide	81298-8110-01	Long Grove Pharmaceuticals, LLC	1	100
Cyclophosphamide	81298-8112-01	Long Grove Pharmaceuticals, LLC	1	200
Cyclophosphamide	81298-8114-01	Long Grove Pharmaceuticals, LLC	1	400

J9075: common questions

Is J9075 a CPT code?: No. J9075 is a HCPCS Level II code, maintained by CMS, that identifies a drug with no specific code of its own. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
What NDC goes with J9075?: None is fixed. J9075 is used for drugs that have no specific HCPCS code, so the claim carries the NDC of the drug actually given and its quantity, and payers usually also ask for the drug name and dose. How to find a J-code.
What is the Medicare payment limit for J9075?: $0.692 per 5 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.

J9075 — Injection, cyclophosphamide, not otherwise specified, 5 mg